Analyst Strong Buy & Buy Stocks
Top 30 results, ranked from our full US coverage.
Every company on this page carries a Strong Buy or Buy consensus from the analysts covering it.
The list is ranked by how far the average price target sits above the current share price, so the biggest implied upside appears first.
Analyst consensus tells you what the sell side expects; the ST Score column next to it tells you what the company's own financial data looks like today.
| # | Symbol | Company | Sector | Price | Market cap | Grade | Analysts | Target upside |
|---|---|---|---|---|---|---|---|---|
| 1 | CETX | Cemtrex, Inc. | Technology | $2.01 | $3.5M | C | Buy | +1201509.8% |
| 2 | XXII | 22nd Century Group, Inc. | Consumer Defensive | $0.87 | $300,499 | C | Buy | +152376.6% |
| 3 | LOCL | Local Bounti Corporation | Consumer Defensive | $1.07 | $24.4M | B- | Buy | +135418.9% |
| 4 | DRCT | Direct Digital Holdings, Inc. | Communication Services | $0.91 | $672,973 | C+ | Buy | +48251.6% |
| 5 | GOVX | GeoVax Labs, Inc. | Healthcare | $0.29 | $2.1M | D+ | Buy | +35487.2% |
| 6 | CALC | CalciMedica, Inc. | Healthcare | $1.30 | $4.1M | B- | Buy | +20844.9% |
| 7 | FBLG | FibroBiologics, Inc. Common Stock | Healthcare | $1.11 | $2.3M | C- | Buy | +15829.2% |
| 8 | SNYR | Synergy CHC Corp. | Healthcare | $0.09 | $941,818 | C+ | Buy | +8187.3% |
| 9 | SURG | SurgePays, Inc. | Technology | $0.15 | $3.7M | C+ | Buy | +6952.2% |
| 10 | ENLV | Enlivex Therapeutics Ltd. | Healthcare | $0.28 | $4.7M | B | Buy | +5805.5% |
| 11 | CRMT | America's Car-Mart, Inc. | Consumer Cyclical | $1.25 | $10.4M | C- | Buy | +4146.7% |
| 12 | CVKD | Cadrenal Therapeutics, Inc. Common Stock | Healthcare | $0.93 | $3.3M | C | Buy | +3416.1% |
| 13 | ACTU | Actuate Therapeutics Inc | Healthcare | $0.68 | $16.2M | C- | Buy | +3341.5% |
| 14 | BNGO | Bionano Genomics, Inc. | Healthcare | $1.46 | $16.8M | B- | Buy | +3140.4% |
| 15 | DVLT | Datavault AI Inc. | Technology | $0.14 | $123.5M | C+ | Buy | +2747.0% |
| 16 | IVF | INVO Fertility, Inc. | Healthcare | $0.74 | $1.3M | C+ | Buy | +2649.1% |
| 17 | PLRX | Pliant Therapeutics, Inc. | Healthcare | $1.00 | $61.9M | C+ | Buy | +2435.3% |
| 18 | GROV | Grove Collaborative Holdings, Inc. | Consumer Defensive | $1.03 | $43.3M | C | Buy | +2361.5% |
| 19 | BIOX | Bioceres Crop Solutions Corp. | Basic Materials | $0.33 | $20.8M | C | Buy | +2336.8% |
| 20 | BEEM | Beam Global | Energy | $1.09 | $24.2M | C+ | Buy | +2236.4% |
| 21 | OWLT | Owlet, Inc. | Healthcare | $4.66 | $84.3M | B- | Buy | +2183.3% |
| 22 | RKDA | Arcadia Biosciences, Inc. | Basic Materials | $0.27 | $423,346 | C+ | Buy | +2170.1% |
| 23 | LIQT | LiqTech International, Inc. | Industrials | $0.45 | $14.8M | C+ | Buy | +2105.9% |
| 24 | ANVS | Annovis Bio, Inc. | Healthcare | $1.17 | $49.8M | C- | Buy | +2021.5% |
| 25 | MLEC | Moolec Science S.A. | Healthcare | $4.19 | $3.0M | C | Buy | +1945.5% |
| 26 | RANI | Rani Therapeutics Holdings, Inc. | Healthcare | $0.79 | $51.7M | C+ | Buy | +1861.2% |
| 27 | INVZ | Innoviz Technologies Ltd. | Consumer Cyclical | $0.31 | $88.5M | C | Buy | +1848.7% |
| 28 | SNTI | Senti Biosciences, Inc. | Healthcare | $0.32 | $10.0M | C- | Buy | +1808.4% |
| 29 | ATOS | Atossa Therapeutics, Inc. | Healthcare | $2.42 | $24.1M | C | Buy | +1641.8% |
| 30 | DCGO | DocGo Inc. | Healthcare | $0.34 | $33.5M | B- | Buy | +1626.8% |
Want to change the thresholds? Open the full stock screener and adjust any of the 100+ filters.
Frequently asked questions
What does a Strong Buy rating mean?
It is the most bullish consensus category, meaning most covering analysts expect the shares to outperform. It reflects analyst opinion, not a guarantee.
How reliable are analyst price targets?
Targets are estimates, usually set on a 12-month view, and they change often. Compare them with the company's ST Score and factor grades rather than relying on them alone.
Why is the upside figure different from the one on the stock page?
Targets and prices update at different times. The figure here uses the latest values from our most recent data run.
Should I buy every Strong Buy stock?
No. This is a research shortlist, not advice. Review each company's valuation, balance sheet and momentum grades before making any decision.
Popular screens
Ready-made lists built from the same data — no filters to set.